Entresto 49 MG-51 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FGAUK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,292
Award facts
- Contract value 100% obligated
- $14,291.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Entresto 49 mg-51 mg tablets (60-count packaging) valued at $14,291.51 under a firm fixed-price contract. This non-set-aside award was competitively procured and is scheduled for completion by September 2, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a ceiling value of $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp serves as a primary pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive portfolio with DLA encompasses brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. Entresto, a cardiovascular medication used in heart failure treatment, aligns with the company's demonstrated capability to supply critical pharmaceutical products to support defense health operations globally. This award reflects AmerisourceBergen's competitive positioning within DLA's pharmaceutical vendor ecosystem and its ability to fulfill time-sensitive medical procurement requirements.
Quick answers
Who was awarded contract SPE2DB25FGAUK?
SPE2DB25FGAUK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 29, 2025.
How much is contract SPE2DB25FGAUK worth?
The government has obligated $14,292 on SPE2DB25FGAUK.
Is contract SPE2DB25FGAUK an order under another contract?
Yes. SPE2DB25FGAUK is a delivery order under SPE2DB24D3015, an indefinite delivery contract.
Was contract SPE2DB25FGAUK competed?
The extent of competition for SPE2DB25FGAUK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award